Issue 10, 2021

Virtual screening and in vitro validation identifies the first reported inhibitors of Salmonella enterica HPPK

Abstract

HPPK, which directly precedes DHPS in the folate biosynthetic pathway, is a promising but chronically under-exploited anti-microbial target. Here we report the identification of new S. enterica HPPK inhibitors, offering potential for new resistance circumventing S. enterica therapies as well as avenues for diversifying the current HPPK inhibitor space.

Graphical abstract: Virtual screening and in vitro validation identifies the first reported inhibitors of Salmonella enterica HPPK

Supplementary files

Article information

Article type
Research Article
Submitted
14 Jul 2021
Accepted
23 Aug 2021
First published
23 Aug 2021

RSC Med. Chem., 2021,12, 1750-1756

Virtual screening and in vitro validation identifies the first reported inhibitors of Salmonella enterica HPPK

R. Müller, T. M. Gerwel, M. P. Kimuda, Ö. T. Bishop, C. G. L. Veale and H. C. Hoppe, RSC Med. Chem., 2021, 12, 1750 DOI: 10.1039/D1MD00237F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements